AA
IMUX icon

ALPS Advisors’s Immunic IMUX Stock Holding History

ALPS Advisors’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$212K Buy
+13,824
New +$171K ﹤0.01% 1155
2022
Q2 		– Sell
-2,868
Closed -$324K – 1062
2022
Q1 		$324K Sell
2,868
-169
-6% -$19.6K ﹤0.01% 738
2021
Q4 		$291K Sell
3,037
-180
-6% -$16.2K ﹤0.01% 838
2021
Q3 		$285K Buy
3,217
+353
+12% +$34.7K ﹤0.01% 870
2021
Q2 		$351K Sell
2,864
-966
-25% -$134K ﹤0.01% 693
2021
Q1 		$610K Buy
3,830
+85
+2% +$14.4K 0.01% 476
2020
Q4 		$573K Buy
+3,745
New +$673K 0.01% 480

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

ALPS Advisors's IMUX Position: Q2 2026 in Review

ALPS Advisors opened a new position in Immunic (IMUX) in Q2 2026: 13,824 shares worth $212K. The stake represents ﹤0.01% of the portfolio and ranks #1155 among its holdings. This is a return to the name: ALPS Advisors previously reported a position in IMUX as recently as Q1 2022.

ALPS Advisors first reported a position in IMUX in Q4 2020 and has held it in 7 quarters since. The position peaked at $610K in Q1 2021. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • ALPS Advisors held 13,824 shares of Immunic worth $212K as of Q2 2026.
  • Immunic was a new ALPS Advisors position in Q2 2026.
  • Immunic made up ﹤0.01% of ALPS Advisors's portfolio in Q2 2026, its #1155 holding.
  • ALPS Advisors first reported a position in Immunic in Q4 2020 and has held it in 7 quarters since.
  • ALPS Advisors's Immunic position peaked at $610K in Q1 2021.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.